secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001193125-23-076793
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health to reaffirm FY2023 guidance and discuss 2027 targets
--------------------------------------------------------------------

- Investor conference on March 23, 2023; webcast at 8:00 a.m. ET.
- FY2023 guidance reaffirmed; no new financial figures provided in filing.
- Long-term financial targets through 2027 to be discussed.
- No specific numbers or changes disclosed; filing is procedural FD disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523076793/0001193125-23-076793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523076793/d483237d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-076793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer